![Bryan Selby](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bryan Selby
Corporate Officer/Principal bei LYELL IMMUNOPHARMA, INC.
Ursprung des Netzwerks ersten Grades von Bryan Selby
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Biotechnology | 28 | |
Public Company | Biotechnology | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bryan Selby
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
ILLUMINA, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Chairman | |
AXSOME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Arbutus Biopharma, Inc.
![]() Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member | |
Stanford University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Doctorate Degree | |
University of Missouri | College/University | Undergraduate Degree Doctorate Degree | |
XENOPORT, INC. | Pharmaceuticals: Major | President Director/Board Member | |
The University of Chicago | College/University | Director/Board Member Undergraduate Degree Doctorate Degree | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member | |
National Academy of Medicine (United States)
![]() National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Society of Clinical Investigation | President Corporate Officer/Principal | ||
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
JUNO THERAPEUTICS INC | Biotechnology | Founder Founder Founder Corporate Officer/Principal | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Roivant Sciences GmbH
![]() Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer President | |
Axovant Sciences, Inc.
![]() Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chairman Chief Executive Officer President | |
GRAIL LLC
![]() GRAIL LLC Medical/Nursing ServicesHealth Services GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Medical/Nursing Services | Director/Board Member Founder Chairman Chief Executive Officer | |
Myovant Sciences, Inc.
![]() Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | President Chief Executive Officer Director/Board Member Chief Executive Officer Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
Dermavant Sciences, Inc.
![]() Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member Director/Board Member | |
Medical Creations, Inc.
![]() Medical Creations, Inc. Medical/Nursing ServicesHealth Services Medical Creations, Inc. engages in the provision of health care services. The company is headquartered in Aspen, CO. | Medical/Nursing Services | Director/Board Member Chairman | |
Urovant Sciences, Inc.
![]() Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder Founder | |
Altavant Sciences, Inc.
![]() Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman | |
Sumitovant Biopharma, Inc.
![]() Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | |
REVOLUTION HEALTHCARE ACQUISITION CORP. | Financial Conglomerates | Founder Founder | |
Altos Labs, Inc.
![]() Altos Labs, Inc. BiotechnologyHealth Technology Altos Labs is a biotechnology company that focuses on cellular rejuvenation programming to restore cell health and resilience. The company is based in Redwood City, CA. The company's goal is to reverse disease and transform medicine. Altos Labs was founded by Rick Klausner and Hans Edgar Bishop. The CEO is Hal V. Barron. | Biotechnology | Director/Board Member Chairman Founder |
Statistik
International
Vereinigte Staaten | 45 |
Vereinigtes Königreich | 5 |
Japan | 2 |
Schweiz | 2 |
Sektoral
Health Technology | 36 |
Consumer Services | 8 |
Finance | 4 |
Health Services | 3 |
Miscellaneous | 2 |
Operativ
Director/Board Member | 289 |
Corporate Officer/Principal | 102 |
Independent Dir/Board Member | 92 |
Chairman | 44 |
Undergraduate Degree | 41 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Robert Nelsen | 80 |
Myrtle Potter | 42 |
Frank Torti | 35 |
Elizabeth Nabel | 32 |
Richard Klausner | 27 |
Hans Bishop | 24 |
Wayne DeVeydt | 24 |
Catherine Friedman | 20 |
Kathleen Sebelius | 18 |
Mark Altmeyer | 16 |
Adele Gulfo | 16 |
Lynn Seely | 16 |
William Rieflin | 16 |
Keith Manchester | 15 |
Otis Brawley | 15 |
- Börse
- Insiders
- Bryan Selby
- Unternehmensverbindungen